Business
Amylyx Pharmaceuticals Won Regulatory Approval for Its Controversial Treatment for ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'Amylyx Pharmaceuticals won regulatory approval for its controversial treatment for amyotrophic lateral sclerosis, making it the third major medicine authorized in the US to slow the disease ...'
Amylyx Pharmaceuticals won regulatory approval for its controversial treatment for amyotrophic lateral sclerosis, making it the third major medicine authorized in the US to slow the disease https://t.co/Z8Zo3VQr9L— Bloomberg (@business) September 29, 2022
(The above story first appeared on LatestLY on Sep 30, 2022 04:17 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
